Imuran and Nasacort drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Imuran (azathioprine) and Nasacort (triamcinolone acetonide). Common drug interactions include urinary tract infection among females and respiratory failure among males.

The phase IV clinical study analyzes what interactions people have when they take Imuran and Nasacort. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Imuran?

Imuran has active ingredients of azathioprine. It is often used in crohn's disease. eHealthMe is studying from 34,915 Imuran users. Check the latest studies of Imuran.

What is Nasacort?

Nasacort has active ingredients of triamcinolone acetonide. It is often used in allergies. eHealthMe is studying from 13,298 Nasacort users. Check the latest studies of Nasacort.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

26 people who take Imuran and Nasacort together, and have interactions are studied.

Imuran and Nasacort drug interactions.

What are the common drug interactions of Imuran and Nasacort, by gender? *:

female:

  1. Urinary tract infection
  2. Abdominal hernia
  3. Anxiety
  4. Blood iron decreased
  5. Body temperature increased
  6. Chest discomfort
  7. Constipation
  8. Depression
  9. Ear infection
  10. Fungal infection

male:

  1. Respiratory failure (inadequate gas exchange by the respiratory system)
  2. Acute respiratory distress syndrome
  3. Pain in extremity
  4. Tremor (trembling or shaking movements in one or more parts of your body)
  5. Bacteraemia (presence of bacteria in the blood)
  6. Bacterial sepsis
  7. Duodenitis (inflammation of the duodenum)
  8. Duodenitis haemorrhagic (inflammation of the duodenum with bleeding disorder)
  9. Gastric ulcer (stomach ulcer)
  10. Gastric ulcer haemorrhage (bleeding ulcer of stomach)

What are the common drug interactions of Imuran and Nasacort, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  2. Dysstasia (difficulty in standing)
  3. Haemorrhagic diathesis (bleeding tendency)
  4. Hepatosplenic t-cell lymphoma (neoplasm comprising medium-sized cytotoxic t-cells that show a significant sinusoidal infiltration in the liver, spleen, and bone marrow)
  5. Mucosal inflammation (infection of mucous membrane)
  6. Neutropenia (an abnormally low number of neutrophils)
  7. Pain in extremity
  8. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  9. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  10. Pruritus (severe itching of the skin)

20-29:

n/a

30-39:

  1. Injection site reaction
  2. Injection site swelling
  3. Nasopharyngitis (inflammation of the nasopharynx)
  4. Oral herpes (viral infection of mouth)
  5. Sinusitis (inflammation of sinus)
  6. Injection site erythema (redness at injection site)
  7. Injection site pain
  8. Injection site pruritus (severe itching at injection site)

40-49:

  1. Abdominal hernia
  2. Blood iron decreased
  3. Constipation
  4. Intestinal resection
  5. Night sweats (sweating in night)

50-59:

  1. Acute respiratory distress syndrome
  2. Respiratory failure (inadequate gas exchange by the respiratory system)
  3. Acute pulmonary histoplasmosis (acute infection by inhalation of spores of the fungus histoplasma capsulatum)
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  6. Pneumonia staphylococcal (pneumonia staphylococcal infections are usually caused by the organism staphylococcus aureus)
  7. Renal failure acute (rapid kidney dysfunction)
  8. Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
  9. Tonsillitis (inflammation of tonsil)
  10. Bacteraemia (presence of bacteria in the blood)

60+:

  1. Body temperature increased
  2. Chest discomfort
  3. Infection
  4. Influenza
  5. Labyrinthitis (inflammation of the labyrinth or inner ear)
  6. Lymphadenopathy (disease or enlargement of lymph nodes)
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Mastoiditis (infection of mastoid bone)
  9. Nasal discomfort
  10. Neck pain

What are the existing conditions these people have? *

  1. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 3 people, 11.54%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 11.54%
  3. Migraine (headache): 3 people, 11.54%
  4. Hypersensitivity: 3 people, 11.54%
  5. Asthma: 3 people, 11.54%
  6. Pain: 2 people, 7.69%
  7. Oral Herpes (viral infection of mouth): 2 people, 7.69%
  8. Immunodeficiency Common Variable: 2 people, 7.69%
  9. High Blood Pressure: 2 people, 7.69%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Imuran and Nasacort?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Imuran and Nasacort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Imuran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nasacort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Imuran and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nasacort and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on azathioprine and triamcinolone acetonide (the active ingredients of Imuran and Nasacort, respectively), and Imuran and Nasacort (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: